Biggest News Aggregation in the World
📰 Nasdaq Huma News

Page 2 - Nasdaq Huma News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Huma. Real-time updates on events, politics, business and more.

Head to Head Survey: Humacyte (NASDAQ:HUMA) and Avalon GloboCare (NASDAQ:ALBT)

Humacyte (NASDAQ:HUMA – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends. Volatility and Risk Humacyte has a beta of […]
United States New Jersey North Carolina Avalon Globocare Humacyte Inc Avalon Globocare Corp

Benchmark Trims Humacyte (NASDAQ:HUMA) Target Price to $15.00

Humacyte (NASDAQ:HUMA – Free Report) had its price target cut by Benchmark from $16.00 to $15.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages also recently weighed in on HUMA. Piper Sandler lowered their price objective on shares […]
United States Piper Sandler Sg Americas Securities Tower Research Capital Humacyte Inc Cantor Fitzgerald

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 10.7% in November

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the recipient of a significant growth in short interest in November. As of November 15th, there was short interest totalling 6,090,000 shares, a growth of 10.7% from the October 31st total of 5,500,000 shares. Based on an average daily trading volume, of 583,200 shares, the short-interest ratio […]
Laurae Niklason Piper Sandler Geode Capital Management Blackrock Inc Cantor Fitzgerald Securities Exchange Commission

Humacyte, Inc. (NASDAQ:HUMA) Short Interest Up 38.2% in September

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) was the target of a large growth in short interest in September. As of September 15th, there was short interest totalling 5,250,000 shares, a growth of 38.2% from the August 31st total of 3,800,000 shares. Based on an average trading volume of 670,100 shares, the short-interest ratio is […]
United States Piper Sandler Laurae Niklason American International Group Inc Cantor Fitzgerald Eudaimonia Partners

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Cantor Fitzgerald Reiterates "Overweight" Rating for Humacyte (NASDAQ:HUMA)

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. Cantor Fitzgerald currently has a $6.00 price objective on the stock. Several other brokerages have also recently weighed in on HUMA. Benchmark reiterated a buy rating and issued a […]
Piper Sandler Laurae Niklason Blackrock Inc Securities Exchange Commission Vanguard Group Inc Humacyte Inc

Humacyte (NASDAQ:HUMA) Earns "Overweight" Rating from Cantor Fitzgerald

Cantor Fitzgerald reaffirmed their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $6.00 target price on the stock. A number of other analysts have also weighed in on HUMA. Benchmark reaffirmed a buy rating and issued a […]
Laurae Niklason Bradyw Dougan Piper Sandler Asset Management Americas Inc Group Plc Cantor Fitzgerald
Source: wkrb13.com

Humacyte's (HUMA) "Overweight" Rating Reiterated at Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Humacyte (NASDAQ:HUMA – Free Report) in a research note issued to investors on Thursday morning, Benzinga reports. The brokerage currently has a $6.00 target price on the stock. A number of other research analysts also recently weighed in on HUMA. Piper Sandler raised Humacyte from an […]
United States Bradyw Dougan Piper Sandler Laurae Niklason American International Group Inc Cantor Fitzgerald

Humacyte (NASDAQ:HUMA) Receives Overweight Rating from Cantor Fitzgerald

Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $6.00 price target on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 68.07% from the company’s previous close. Other […]
Laurae Niklason Piper Sandler York Mellon Corp Blackrock Inc Advisor Group Holdings Inc Humacyte Inc

Humacyte, Inc. (NASDAQ:HUMA) CEO Laura E. Niklason Sells 602,443 Shares

Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) CEO Laura E. Niklason sold 602,443 shares of the stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $3.39, for a total transaction of $2,042,281.77. Following the sale, the chief executive officer now directly owns 8,191,140 shares of […]
Laurae Niklason Piper Sandler Wells Fargo Company Rokos Capital Management Humacyte Inc Osaic Holdings Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science